What is the Fiscal Year for Veru?
Date: November 13, 2026
Veru's current fiscal year starts on October 1, 2026, and ends on September 30, 2027. Their current quarter is Q1, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
October 1, 2026
Fiscal Year End
September 30, 2027
Current Quarter
Q1
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Oct 1, 2026 – Dec 31, 2026
Q2
Jan 1, 2027 – Mar 31, 2027
Q3
Apr 1, 2027 – Jun 30, 2027
Q4
Jul 1, 2027 – Sep 30, 2027
Company Information
Headquarters
Miami, Florida, United States
Industry
Healthcare, Biotechnology Research Services
Stock Symbol
VERU
Website
https://verupharma.comDescription
Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass thereby improving body composition and physical function. Sabizabulin, a microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Veru and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.